In this study, a panel of eight-gene signature comprising CNKSR1, CXorf57, FASN, SPINT1, COPZ2, PCOLCE2, TPST1, and RGS1 was finally selected to generate a risk score model which can be exploited for predicting survival in BC. Here, COPZ2 is linked to breast cancer.